GE Healthcare Technologies Inc. (GEHC) presents a mixed investment opportunity based on current market analysis and analyst recommendations.
## Analyst Recommendations and Forecasts
GE Healthcare Technologies has a consensus rating of “Moderate Buy” based on 10 buy ratings and 4 hold ratings, with no sell ratings[1]. Another source indicates that among 7 Wall Street analysts covering the stock, the consensus is a “Strong Buy” with 4 analysts (57.14%) recommending GEHC[4].
The stock recently closed at $69.85 on Friday, May 9, 2025, after declining 0.92% from $70.50[2]. During that trading day, the stock fluctuated 2.72% between a low of $69.79 and a high of $71.69[2]. Despite this recent performance, the stock has gained 2.09% over the past two weeks[2].
Some notable analyst price targets include:
– Citigroup: $86.00 (23.09% upside potential) – Maintained “Strong Buy” on April 30, 2025[4]
– Piper Sandler: $88.00 (25.95% upside potential) – Maintained “Strong Buy” on April 23, 2025[4]
– Jefferies: $103.00 (47.42% upside potential) – Upgraded on January 8, 2025[4]
## Growth and Financial Metrics
GEHC has a Growth Grade of B according to one source[3], though another indicates a Growth Grade of C[3]. The company shows some positive financial indicators:
– Cash from Operations has been positive for the last 5 years (5 out of 5 years)[3]
– Sales have increased year-over-year in 4 out of the last 5 years[3]
However, the company’s 5-year annual sales growth rate is 0.0%, significantly lower than the sector median of 10.9%[3].
## Short-Term vs. Long-Term Outlook
In the short term, the stock lies in the upper part of a wide and falling trend, which might present a selling opportunity for short-term traders[2]. The stock is expected to fall 31.04% during the next 3 months with a 90% probability of trading between $32.81 and $48.27 at the end of this period[2].
However, some sources suggest that despite being in a falling trend, the current level may present a buying opportunity as several short-term signals are positive[2].
According to Zacks Rank, GEHC is rated as a #3 (Hold) with a VGM Score of B and a Value Style Score of B, suggesting attractive valuation metrics[5].
## Conclusion
Whether GEHC is a good stock to buy depends on your investment strategy, time horizon, and risk tolerance. For long-term investors, the positive analyst ratings and potential upside based on price targets could make it an attractive option. For short-term traders, caution may be warranted given the predicted short-term downtrend.
Before investing, consider comparing GEHC with its competitors in the Advanced Medical Equipment & Technology industry and evaluating how it aligns with your overall investment goals and portfolio allocation.